Overview

Evaluation of Testosterone Nasal Gel in Hypogonadal Boys

Status:
Unknown status
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
PK study to evaluate serum levels of testosterone post nasal delivery in two cohorts of hypogonadal boys.
Phase:
Phase 1
Details
Lead Sponsor:
Acerus Biopharma Inc.
Acerus Pharmaceuticals Corporation
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate